Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Reducing air pollution associated with lower risk of all-cause dementia and Alzheimer's disease

Previous reports have linked long-term air pollution exposure with accumulation of Alzheimer's disease-related brain plaques, but this is the first accumulated evidence that reducing pollution, especially fine particulates in the air and pollutants from the burning of fuel, is associated with lower risk of all-cause dementia and Alzheimer's disease.

27 Oct 2023

Single-cell proteomics – when mass spectrometry revolutionizes biomedical research

In the latest episode of the OMG Omx podcast, Bruker's Kate Stumpo talks to Nikolai Slavov about the incredible potential of mass spectrometry proteomics in biomedical research.

From Bruker Daltonics 27 Oct 2023

Doubts abound about a new Alzheimer’s blood test

For the first time, people worried about their risk of Alzheimer's disease can go online, order a blood test, and receive results in the privacy of their homes.

26 Oct 2023

Older adults with higher levels of triglycerides may have lower dementia risk

Older people who have higher levels of triglycerides, a type of fat, may have a lower risk of dementia and a slower cognitive decline over time compared to people who have lower levels, according to new research published in the October 25, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

25 Oct 2023

Traumatic childhood events increase the odds of headache disorders in adulthood

People who have experienced traumatic events in childhood such as abuse, neglect or household dysfunction may be more likely to experience headache disorders as adults, according to a meta-analysis published in the October 25, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

25 Oct 2023

Millions of Americans with mild cognitive impairment are undiagnosed, studies find

For many people, forgetting your keys or struggling to plan tasks can seem like a normal part of the aging process. But those lapses can actually be symptoms of something more serious: mild cognitive impairment, or MCI, which could be an early sign of Alzheimer's disease.

25 Oct 2023

New smartphone attachment could enable low-cost neurological screening for all

Engineers at the University of California San Diego have developed a smartphone attachment that could enable people to screen for a variety of neurological conditions, such as Alzheimer's disease and traumatic brain injury, at low cost - and do so accurately regardless of their skin tone.

25 Oct 2023

Dementia and cholesterol: investigating links and impacts of hormone replacement therapy

The relationships between hormone replacement therapy (HRT), serum cholesterol levels, and dementia incidence.

25 Oct 2023

Abnormal electrical activity in the brain of people with Alzheimer's leads to epileptic seizures

Alzheimer's disease causes death of neurons, and researchers hypothesize this may contribute to abnormal electrical activity in the brain that leads to epileptic seizures.

23 Oct 2023

Is COVID-19 a risk factor for Alzheimer's disease?

The study explores the interconnected risks between COVID-19 and Alzheimer's Disease (AD), highlighting how SARS-CoV-2 can aggravate AD pathology through neuroinflammation and neurodegeneration. It raises significant concerns about the long-term cognitive implications of COVID-19, especially among those already at risk for AD.

23 Oct 2023

Shedding light on the future of cognitive health in a graying world

Age-related cognitive decline and changes in the brain.

23 Oct 2023

Can Beta-carotene boost cognitive health? Study reveals promising insights

A systematic review explores the potential of β-carotene in enhancing cognitive function, revealing its potential benefits and the importance of dietary interventions for cognitive health.

22 Oct 2023

DASH diet may help preserve cognitive function in women later in life

Women with diets during middle age designed to lower blood pressure were about 17 percent less likely to report memory loss and other signs of cognitive decline decades later, a new study finds.

20 Oct 2023

UCSF dementia experts to join peers at annual Clinical Trials on Alzheimer's disease conference

Dementia experts from UC San Francisco will join their peers from around the globe at the annual Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston from Oct. 24 to 27.

19 Oct 2023

Identifying a signature biomarker for early-onset Alzheimer's disease

Alexandra Touroutoglou, PhD, and Bradford Dickerson, MD, neuroscientists in the department of Neurology at Massachusetts General Hospital, are the lead authors of a new study published in Alzheimer's & Dementia, The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort.

19 Oct 2023

Study explores sex-specific effects in Alzheimers disease pathology

The role of biological sex in the development and progression of Alzheimer's Disease (AD).

19 Oct 2023

New model helps to better understand how Alzheimer's disease progresses in the brain

A new model developed by Van Andel Institute, Lund University and University of Florence scientists will enable researchers to better understand how Alzheimer's disease progresses in the brain.

18 Oct 2023

COVID-19 infection associated with increased risk of developing Guillain-Barré syndrome

Having a COVID-19 infection is associated with an increased risk of developing the rare disorder called Guillain-Barré syndrome within the next six weeks, according to a study published in the October 18, 2023, online issue of Neurology, the medical journal of the American Academy of Neurology.

18 Oct 2023

Review highlights the potential mechanistic links between COVID-19 and Alzheimer's disease

The various neurological symptoms that patients with COVID-19 have experienced suggest that viral infections may increase the risk of neurodegeneration, which could in turn contribute to the development of conditions such as Alzheimer's disease (AD).

18 Oct 2023

Gut microbiota linked to Alzheimer's disease

Researchers have discovered the link between the gut microbiota and Alzheimer's disease.

17 Oct 2023

Alzheimer's Disease News and Research

Further Reading

Reducing air pollution associated with lower risk of all-cause dementia and Alzheimer's disease

Single-cell proteomics – when mass spectrometry revolutionizes biomedical research

Doubts abound about a new Alzheimer’s blood test

Older adults with higher levels of triglycerides may have lower dementia risk

Traumatic childhood events increase the odds of headache disorders in adulthood

Millions of Americans with mild cognitive impairment are undiagnosed, studies find

New smartphone attachment could enable low-cost neurological screening for all

Dementia and cholesterol: investigating links and impacts of hormone replacement therapy

Abnormal electrical activity in the brain of people with Alzheimer's leads to epileptic seizures

Is COVID-19 a risk factor for Alzheimer's disease?

Shedding light on the future of cognitive health in a graying world

Can Beta-carotene boost cognitive health? Study reveals promising insights

DASH diet may help preserve cognitive function in women later in life

UCSF dementia experts to join peers at annual Clinical Trials on Alzheimer's disease conference

Identifying a signature biomarker for early-onset Alzheimer's disease

Study explores sex-specific effects in Alzheimers disease pathology

New model helps to better understand how Alzheimer's disease progresses in the brain

COVID-19 infection associated with increased risk of developing Guillain-Barré syndrome

Review highlights the potential mechanistic links between COVID-19 and Alzheimer's disease

Gut microbiota linked to Alzheimer's disease

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News